Corticobasal degeneration: A review of the literature;La degenerescence corticobasale

Revue Neurologique

Volumn 155, Issue 12, 1999, Pages 1007-1020

  Ozsancak C ^a,b   Auzou, P ^a   Hannequin, D ^a  

^a Fed des Sciences Neurologiques   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CORTICOSTEROID; FLUORINE DERIVATIVE; LEVODOPA; PIRACETAM; PROPRANOLOL; VALPROIC ACID;

CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KINESIOTHERAPY; MUSCLE HYPERTONIA; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL THERAPY; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMOTOMY; AGED; BRAIN CORTEX; EXTRAPYRAMIDAL SYNDROME; FEMALE; MALE; MIDDLE AGED; NERVE DEGENERATION; PARKINSON DISEASE; PATHOLOGY;

AGED; BASAL GANGLIA DISEASES; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; PARKINSON DISEASE;

EID: 0033431669     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (156)

1. ARIMA K., UESUGI H., FUJITA I., SAKURAI Y. et al. (1994). Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: Ultrastructural and immunocytochemical studies. J Neurol Sci, 127: 186-197.
2. BALDWIN B., FÖRSTL H. (1993). "Pick's disease"-101 years on still there, but in need of reform. Br J Psychiat, 163: 100-104.
3. BALL J.A., LANTOS P.L., JACKSON M., MARSDEN C.D. et al. (1993). Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry, 56: 1020-1023.
4. BALLAN G., TISON F., DOUSSET V., VIDAILHET M. et al. (1996). Magnetic resonance imaging (MRI) in corticobasal degeneration. Mov Disord, 11 (Suppl 1): 112.
5. BALLAN G., TISON F., DOUSSET V., VIDAILHET M. et al. (1998). Étude de l'atrophie corticale par imagerie magnétique dans la dégéné-rescence cortico-basale. Rev Neurol (Paris), 154: 224-227.
6. BARCLAY C.L., LANG A.E. (1997). Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 62: 352-356.
7. BEATTY W.W., SCOTT J.G., WILSON D.A., PRINCE J.R. et al. (1995). Memory deficits in a demented patient with probable corticobasal degeneration. J Geriat Psychiat Neurol, 8: 132-136.
8. BERGERON C., POLLANEN M.S., WEYER L., BLACK S.E. et al. (1996). Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol, 40: 893-900.
9. BLIN J., BARON J.C., DUBOIS P., PILLON B. et al. (1990). Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol, 47: 747-752.
10. BLIN J., VIDAILHET M.J., PILLON B., DUBOIS B. et al. (1992). Corticobasal degeneration: Decreased and asymetrical glucose consumption as studied with PET. Mov Disord, 7: 348-334.
11. BLONDEL A., EUSTACHE F., SCHAEFFER S., MARIÉ R.M. et al. (1997). Étude clinique et cognitive de l'apraxie dans l'atrophie corticobasale: Un trouble sélectif du système de production. Rev Neurol (Paris), 12: 737-748.
12. BOEVE B.F., MARAGANORE D.M., PARISI J.E., AHLSKOG J.E. et al. (1996). Clinical heterogeneity in patients with pathologically diagnosed cortico-basal ganglionic degeneration. Mov Disord, 11: 351.
13. BROOKS D.J. (1996). PET studies on corticobasal degeneration. Mov Disord, 11: 349.
14. BROWN J., LANTOS P.L., ROQUES P., FIDANI L. et al. (1996). Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: A clinical and pathological study. J Neurol Sci, 735: 21-30.
15. BRUNT E.R., VAN WEERDEN T.W., PRUIM J., LAKKE J.W. (1995). Unique myoclonic pattern in corticobasal degeneration. Mov Disord, 10: 132-142.
16. BUCHMAN A.S., GOETZ C.G., KLAWANS H.L. (1988). Hemiparkinsonism with hemiatrophy. Neurology, 38: 527-530.
17. BUÉE-SCHERRER V., HOF P.R., BUÉE L., LEVEUGLE B. et al. (1996). Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol, 91: 351-359.
18. CAMBIER J., MASSON M., DAIROU R., HENIN D. (1981). Étude anatomo-clinique d'une forme pariétale de maladie de Pick. Rev Neurol (Paris), 137: 33-38.
19. CARELLA F., CIANO C., PANZICA F., SCAIOLI V. (1997). Myoclonus in corticobasal degeneration. Mov Disord, 12: 598-603.
20. CARELLA F., SCAIOLI V., FRANCESCHETTI S., GIROTTI F. et al. (1991). Focal reflex myoclonus in corticobasal degeneration. Funct Neurol, 6: 165-170.
21. CECCALDI M., PONCET M., GAMBARELLI D., GUINOT H. et al. (1995). Apraxie unilatérale gauche d'aggravation progressive dans deux cas de maladie d'Alzheimer. Rev Neurol (Paris), 151: 240-246.
22. CHARI G., HAUSER R. (1997). Prolonged isolated limb dystonia as the initial manifestation of corticobasal degeneration. Mov Disord, 12:41.
23. CHEN R., ASHBY P., LANG A.E. (1992). Stimulus sensitive myoclonus in akinetic-rigid syndromes. Brain, 115: 1875-1988.
24. CLARK A.W., MANZ H.J., WHITE C.L., LEHMANN J. et al. (1986). Cortical degeneration with swollen chromatolytic neurons: Its relationship to Pick's disease. J Neuropathol Exp Neurol, 45: 268-284.
25. COOPER P.N., JACKSON M., LENNOX G., LOWE J. et al. (1995). Tau, ubiquitin, and alpha-B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol, 52: 1011-1015.
26. COSTA B., ZANETTE G., BERTOLASI L., FIASCHI A. (1994). Hemiparkinsonism-hemiatrophy syndrome: Neuroradiological and neurophysiological findings. Eur Neurol, 34:107-109.
27. CRYSTAL H.A., HOROUPIAN D.S., KATZMAN R., JOTKOWITZ S. (1982). Biopsy-proved Alzheimer disease presenting as a right parietal syndrome. Ann Neurol, 12: 186-188.
28. D'ANTONA R., BARON J.C., SAMSON Y., SERDARU M. et al. (1985). Subcortical dementia: Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain, 108: 785-799.
29. DELACOURTE A., SERGEANT N., WATTEZ A., GAVREAU D. et al. (1998a). Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann Neurol, 43: 193-204.
30. DELACOURTE A., SERGEANT N., WATTEZ A., ROBITAILLE Y. (1998b). The biochemistry of the cytoskeleton in Pick Complex. In Kertesz A., Munoz D.G. (eds.), Pick's disease and Pick complex, pp. 243-258. Wiley-Liss, Inc., New York.
31. DELACOURTE A., ROBITAILLE Y., SERGEANT N., BUEE L et al. (1996). Specific pathological tau protein variants characterize Pick's disease. J Neuropat Exp Neurol, 55: 159-168.
32. DICKSON D.W. (1997). Neurodegenerative diseases with cytoskeletal pathology: A biochemical classification. Ann Neurol, 42: 541-543.
33. DICKSON D.W., FEANY M.B., YEN S.H., MATTIACE L.A. et al. (1996). Cytoskeletal pathology in non-Alzheimer degenerative dementia: New lesions in Diffuse Lewy Body disease, Pick's disease, and Corticobasal degeneration. J Neural Transm, 47: 31-46.
34. DOODY R.S., JANKOVIC J. (1992). The alien hand and related signs. J Neurol Neurosurg Psychiatry, 55: 806-810.
35. DURIEU I., SALMON E., DESTEE A., DELAFOSSE A. (1996). Corticobasal degeneration (CBD) with severe buccofacial apraxia and anarthria. Mov Disord, 11: 165.
36. DUVOISIN R.C. (1994). Differential diagnosis of PSP. J Neural Transm, 42: 51-67.
37. EBERHARD D.A., LOPES M.B., TRUGMAN J.M., BRASHEAR H.R. (1996). Alzheimer's disease in a case of cortical basal ganglionic degeneration with severe dementia. J Neurol Neurosurg Psychiatry, 60: 109-110.
38. EIDELBERG D., DHAWAN V., MOELLER J.R., SIDTIS J.J. et al. (1991). The metabolic landscape of cortico-basal ganglionic degeneration: Regional asymetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry, 54: 856-862.
39. EIDELBERG D., MOELLER J.R., SIDTIS J.J., DHAWAN D. et al. (1989). Corticodentatonigral degeneration: Metabolic asymmetries studied with 18F-fluorodeoxyglucose and positron emission tomography. Neurology, 39: 164.
40. FAYET G., VERCELLETTO M., BERTOUT C., DE KERSAINT-GILLY A. et al. (1995). Anarthrie, apraxie progressive et syndrome extrapyramidal : forme clinique particulière de dégénérescence cortico-basale ? Un cas avec étude en tomographie par émission monophotonique au HMPAO Tc 99M. Rev Neurol (Paris), 151 : 247-250.
41. FEANY M.B., DICKSON D.W. (1995). Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol, 146: 1388-1396.
42. FEANY M.B., DICKSON D.W. (1996). Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol, 40: 139-148.
43. FEANY M.B., KSIEZAK-REDING H., LIU W.K., VINCENT I. et al. (1995). Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: Differentiation from progressive supranuclear palsy. Acta Neuropathol, 90: 37-43.
44. FETONI V., MONZO D., AUSTONI L., SOLIVERI P. et al. (1996). Pattern of cognitive alteration and organisation of complex motility in corticobasal degeneration. Mov Disord, 11 (Suppl 1): 164.
45. FORD B., GREENE P., FAHN S. (1996). 60-year-old woman with parkinsonism and unilateral dystonia. Mov Disord, 11: 355-356.
46. FRISONI G.B., PIZZOLATO G., ZANETTI O., BIANCHETTI A. et al. (1995). Corticobasal degeneration: Neuropsychological assessment and dopamine D2 receptor SPECT analysis. Eur Neurol, 35: 50-54.
47. GIBB W.R.G., LUTHERT P.J., MARSDEN C.D. (1989). Corticobasal degeneration. Brain, 112: 1171-1192.
48. GIBB W.R., LUTHERT P.J., MARSDEN CD. (1990). Clinical and pathological features of corticobasal degeneration. Adv Neurology, 53: 51-54.
49. GILADI N., FAHN S. (1992). Hemiparkinsonism-hemiatrophy syndrome may mimic early stage cortical-basal ganglionic degeneration. Mov Disord, 7: 384-385.
50. GIMÉNEZ-ROLDAN S., MATEO D., BENINO C., GRANDAS F. et al (1994). Progressive supranuclear palsy and corticobasal ganglionic degeneration: Differentiation by clinical and neuroimaging techniques. J Neural Transm, 42: 79-90.
51. GOETZ C.G., KOMPOLITI A., GREENE P.E., RILEY D.E. et al. (1996). Pharmacological therapy in corticobasal ganglionic degeneration. Mov Disord, 11: 350.
52. GOLBE L.I. (1990). Single-photon emission computed tomography imaging in cortico-basal degeneration. Ann Neurol, 28: 298-299.
53. GRAS P., CREISSON E., GIROUD M., DUMAS R. et al. (1994). Dégéné rescence corticobasale : Une nouvelle entité (corticobasal degeneration). Presse Med, 23: 1772-1774.
54. GREENE P.E., FAHN S., LANG A.E., WATTS R.L. et al. (1990). What is it? Case 1 1990. Progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to a fixed postural deformity of the involved limb. Mov Disord, 5: 341-351.
55. GREENE P.E., PRZEDBORSKI S., KOSTIC V., GILADI N. et al. (1991). Cortico-basal ganglionic degeneration: Survey of 18 clinically diagnosed patients, (abstract) Neurology, 41(suppl1) : 344.
56. GRISOLI M., FETONI V., SAVOIARDO M., GIROTTI F. et al. (1995). MRI in corticobasal degeneration. Eur J Neurol, 2: 547-552.
57. HABIB M., ALICHERIF A., BALZAMO M., MILANDRE L. et al. (1995). Caractérisation du trouble gestuel dans l'apraxie progressive primaire : Apport diagnostique et nosographique. Rev Neurol (Paris), 151 : 541-551.
58. HALLIDAY G.M., DAVIES L., MCRITCHIE D.A., Cartwright H. et al. (1995). Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathol, 90: 68-75.
59. HAUSER R.A., MURTAUGH F.R., AKHTER K., GOLD M. et al. (1996a). Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging, 6: 222-226.
60. HAUSER R.A., MURTAUGH F.R., OLANOW C.W. (1996b). Magnetic resonance imaging (MRI) in corticobasal degeneration. Mov Disord, 11: 352.
61. HOROUPIAN D.S., CHU P.L. (1994). Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles. Acta Neuropathol, 88: 592-598.
62. IKEDA K. (1997). Basic pathology of corticobasal degeneration. Neuropathology, 77: 127-133.
63. IKEDA K., AKIYAMA H., IRITANI S., KASE K. et al. (1996). Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: Case report and review. Acta Neuropathol, 92: 534-539.
64. JACKSON M., LOWE J. (1996). The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol, 91: 127-134.
65. JACOBS D.H., ADAIR J.C., HEILMAN K.M. (1994). Visual grasp in corticobasal degeneration. Ann Neurol, 36: 679-680.
66. JACOBS D.H., BOSTON M.A., ADAIR J.C., MACAULEY B.L. et al. (1995). Apraxia in corticobasal degeneration (CBD). Neurology, 45: A266-A267.
67. JENDROSKA K., ROSSOR M.N., MATHIAS C.J., DANIEL S.E. (1995). Morphologic overlap between corticobasal degeneration and Pick's disease: A clinicopathological report. Mov Disord, 10: 111-114.
68. KERTESZ A. (1997). Frontotemporal dementia, Pick Disease and Corticobasal Degeneration. One entity or 3? 1. Arch Neurol, 54: 1427-1428.
69. KERTESZ A. (1998). Pick's disease and Pick complex: Introductory Nosology. In Kertesz A., Munoz D.G. (eds.), Pick's disease and Pick complex, pp. 1-11. Wiley-Liss, Inc., New York.
70. KERTESZ A., HUDSON L., MCKENZIE I.R., MUNOZ D.G. (1994). The pathology and nosology of progressive primary aphasia. Neurology, 44: 2065-2072.
71. KERTESZ A., MARTINEZ-LAGE P. (1998). Cognitive changes in corticobasal degeneration. In Kertesz A., Munoz D.G. (eds.), Pick's disease and Pick complex, pp. 121-128. Wiley-Liss, Inc., New York.
72. KERTESZ A., MUNOZ D.G. (1997). Primary progressive aphasia. Clin Neurosci, 42: 95-102.
73. KOMPOLITI A., GOETZ C.G., GREENE P.E., PRZEDBORSKI S. et al. (1996). The clinical spectrum of corticobasal ganglionic degeneration (CBGD). Mov Disord, 11 (Suppl 1) : 160.
74. KSIEZAK-REDING H., TRACZ E., YANG L.S., DICKSON D.W. et al. (1996). Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy. Am J Pathol, 149: 639-651.
75. LANG A.E. (1992). Cortical basal ganglionic degeneration presenting with "progressive loss of speech output and orofacial dyspraxia". J Neurol Neurosurg Psychiatry, 55: 1101.
76. LANG A.E., RILEY D.E., BERGERON C. (1994a). Cortical-Basal Ganglionic Degeneration. In Calne D.B. (ed.), Neurodegenerative diseases, pp. 877-894. WB Saunders, Philadelphia.
77. LANG A.E., BERGERON C., POLLANEN M.S., ASHBY P. (1994b). Parietal Pick's disease mimicking cortico-basal ganglionic degeneration. Neurology, 44: 1436-1440.
78. LEIGUERDA R., LEES A.J, MERELLO M., STARKSTEIN S. et al. (1994). The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry, 57: 455-459.
79. LENNOX G., JACKSON M., LOWE J. (1994). Corticobasal degeneration manifesting as frontal lobe dementia. Ann Neurol, 36: 273-274.
80. LERNER A., FRIEDLAND R., RILEY D., WHITEHOUSE P. et al. (1992). Dementia with pathological findings of cortico-basal ganglionic degeneration. Ann Neurol, 32: 271.
81. LE WITT P., FRIEDMAN J., NUTT J., KORCZYN A. et al. (1989). Progressive rigidity with apraxia: The variety of clinical and pathological features. Neurology, 39: 140.
82. LIPPA C.F., COHEN R., SMITH T.W., DRACHMAN D.A. (1991). Primary progressive aphasia with focal neuronal achromasia. Neurology, 41: 882-886.
83. LIPPA C.F., SMITH T.W., FONTNEAU N. (1990). Corticonigral degeneration with neuronal achromasia. J Neurol Sci, 96: 301-310.
84. LITVAN I., AGID Y., GOETZ C., JANKOVIC J. et al. (1997a). Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study. Neurology, 48: 119-125.
85. LITVAN I., CAMPBELL G., MANGONE C.A., VERNY M. et al. (1997b). Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olzsewski syndrome) from related disorders? A clinicopathological study. Brain, 120: 65-74.
86. LITVAN I., CUMMINGS J., MEGA M. (1997c). Neuropsychiatric features of corticobasal degeneration. Ann Neurol, 42: 395.
87. LITVAN I., HAUW J.J., BARTKO J.J., LANTOS P.L. et al. (1996). Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol, 55: 97-105.
88. Lu C.S., IKEDA A., TERADA K., MIMA T. et al. (1998). Electrophysiological studies of early stage corticobasal degeneration. Mov Disord, 13: 140-146.
89. LUND and MANCHESTER Groups. (1994). Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry, 57: 416-418.
90. MARKUS H,S., LEES A.J., LENNOX G., MARSDEN C.D. et al. (1995). Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord, 10: 179-187.
91. MARSHALL E.F., PERRY R.H., PERRY E.K., PIGGOTT M.A. et al. (1997). Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration. Acta Neurol Scand, 95: 287-292.
92. MASSMAN P.J., KREITER K.T., JANKOVIC J., DOODY R.S. (1996). Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology, 46: 720-726.
93. MATSUMOTO S., UDAKA F., KAMEYAMA M., KUSAKA H. et al. (1996). Subcortical neurofibrillary tangles, neuropil threads, and argentophilic glial inclusions in corticobasal degeneration. Clin Neuropathol, 15: 209-214.
94. MIMURA M., WHITE R.F., ALBERT M.L. (1997). Corticobasal degeneration: neuropsychological and clinical correlates. J Neuropsychiatr Clin Neurosc, 9: 94-98.
95. MITANI K., FURIYA Y., UCHIHARA T., ISHII K. et al. (1998). Increased CSF tau protein in corticobasal degeneration. J Neurol, 245: 44-46.
96. MORI H., NISHIMURA M., NAMBA Y., ODA M. (1994). Corticobasal degeneration: A disease with widespread appearance of abnormal tau and neurofibrillary tangles and its relation to progressive supranuclear palsy. Acta Neuropathol, 88: 113-121.
97. MORIMATSU M., NEGORO K. (1995). Corticobasal degeneration: symptomatological, brain imaging and electrophysiological studies. CLIN NEUROL, 35: 1459-1462.
98. MUHIDDIN K.A., HARDIE R.J., PEARCE V.R., KIRBY B.J. (1994). Corticobasal degeneration: A report of three cases. J Royal Soc Med, 87: 359-360.
99. NAGAHAMA Y., FUKUYAMA H., TURJANSKI N., KENNEDY A. et al. (1997). Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls. Mov Disord, 12: 691-696.
100. NAGASAWA H., TANJI H., NOMURA H., SAITO H. et al. (1996). PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. J Neurol Sci, 139: 210-217.
101. OKUDA B., TACHIBANA H. (1994). The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry, 57: 1548-1549.
102. OKUDA B., TACHIBANA H., KAWABATA K, TAKEDA M. et al. (1992). Slowly progressive limb kinetic apraxia with a decrease in unilateral cerebral blood flow. Acta Neurol Scand, 86: 76-81.
103. OKUDA B., TACHIBANA H., TAKEDA M., KAWABATA K. et al. (1995). Focal cortical hypoperfusion in corticobasal degeneration demonstrated by three dimensional surface display with 123l-IMP: A possible cause of apraxia. Neuroradiol, 37: 642-644.
104. OTSUKA M., ICHIYA Y., KUWABARA Y., SASAKI M. et al. (1995). Nigrofrontal dopaminergic function as assessed by 18F-dopa PET. Nucl Med Commun, 16: 1021-1025.
105. PAPP M.I., KOHN J.E., LANTOS P.L. (1989). Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy and Shy-Drager syndrome. J Neurol Sci, 94: 79-100.
106. PASQUIER F., LEBERT F. (1995). Les démences fronto-temporales. In Compte-rendu du Congrès de Psychiatrie et de Neurologie de Langue Française. Masson, Paris.
107. PAULUS W., SELIM M. (1990). Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol, 81: 89-94.
108. PIERROT-DESEILLIGNY C., RIVAUD S., GAYMARD B., AGID Y. (1991). Cortical control of visually-guided saccades. Brain, 114: 1473-1485.
109. PILLON B., DUBOIS B., AGID Y. (1996a). Testing cognition may contribute to the diagnosis of movement disorders. Neurology, 46: 329-334.
110. PILLON B., VIDAILHET M., SIRIGU A., AGID Y. et al. (1996b). The cognitive syndrome of corticobasal degeneration. Mov Disord, 11: 354.
111. PILLON B., BLIN J., VIDAILHET M.J., DEWEER B. et al. (1995). The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology, 45: 1477-1483.
112. QUINN N. (1989). Disproportionate antecollis in multiple system atrophy. Lancet, 8642: 844.
113. RASCOL O., SABATINI U., SIMONETTA-MOREAU M., MONTASTRUC J.L. et al. (1991). Square wave jerks in parkinsonian syndromes. Abnormal ocular movements in Parkinson's disease. J Neurol Neurosurg Psychiatry, 54: 599-602.
114. REBEIZ J.J., KOLODNY E.H., Richardson E.P. (1968). Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol, 18: 20-33.
115. REY G.J., TOMER R., LeVIN B.E., SANCHEZ-RAMOS J. et al. (1995). Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration. Mov Disord, 10: 106-110.
116. RILEY D.E. (1996a). Atypical features and variant presentations of cortical-basal ganglionic degeneration. Mov Disord, 11: 347.
117. RILEY D.E. (1996b). Alzheimer's disease (AD) with a clinical presentation mimicking cortical-basal ganglionic degeneration. Mov Disord, 11: 357.
118. RILEY D.E, LANG A.E. (1988). Cortico-basal ganglionic degeneration (CBGD): Further observations on six additional cases. Neurology, 38 (suppl 1): 360.
119. RILEY D.E, LANG A.E., LEWIS A., RESCH L. et al. (1990). Cortical-basal ganglionic degeneration. Neurology, 40:1203-1212.
120. RINNE J.O., LEE M.S., THOMPSON P.D., MARSDEN C.D. (1994). Corticobasal degeneration. A clinical study of 36 cases. Brain, 117: 1183-1196.
121. RIVEST J., QUINN N., MARSDEN C.D. (1990). Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology, 40: 1571-1578.
122. ROSENFIELD D.B., BOGATKA C.J., VISWANATH N.S., LANG A.E. et al. (1991). Speech apraxia in cortical-basal ganglionic degeneration. Ann Neurol, 30: 296-297.
123. ROTTACH K.G., RILEY D.E., DI SCENNA A.O., ZIVOTOFOSKY A.Z. et al. (1996). Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol, 39: 368-377.
124. SAINT-HILAIRE M.H., HANDLER J., McKEE A.C., FELDMAN R.G. (1996). Clinical overlap between corticobasal ganglionic degeneration and progressive supranuclear palsy. Mov Disord, 11: 356.
125. SAKURAI Y., HASHIDA H., UESEGI H., ARIMA K. et al. (1996). A clinical profile of corticobasal degeneration presenting as primary progressive aphasia. Eur Neurol, 36: 134-137.
126. SAVOIARDO M., GIROTTI F., STRADA L., CICERI E. (1994). Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm, 42: 93-110.
127. SAWLE G.V., BROOKS D.J., MARSDEN C.D., FRACKOWIAK R.S.J. (1991). Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain, 114: 541-556.
128. SAWLE G.V., BROOKS D.J., THOMPSON P.D., MARSDEN C.D. et al. (1989). PET studies on the dopaminergic system and regional cortical metabolism in corticobasal degeneration. Neurology, 39 (suppl 1): 163.
129. SCHNEIDER J.A., WATTS R.L., GEARING M., BREWER R.P. et al. (1997). Corticobasal degeneration: Neuropathologic and clinical heterogeneity. Neurology, 48: 959-969.
130. SCULLY R.E., MARK E.J., MCNEELY B.U. (1985). Case records of the Massachusetts General Hospital. N Engl J Mod, 313: 739-748.
131. SCULLY R.E., MARK E.J., MCNEELY W.F., MCNEELY B.U. (1993). Case records of the Massachusetts General Hospital. N Engl J Med, 329: 1560-1567.
132. SEAL E.C., HAIGHT P.L., BURNS R.S. (1996). A formal study of speech and language changes in the syndrome of corticobasal ganglionic degeneration: Is initial dominant hemisphere involvement a predictor of language impairment? Mov Disord, 11: 353.
133. SHANNON K.M., PAPPERT E.J., LIPTON J.W., MCRAE A. et al. (1996). Corticobasal ganglionic degeneration (CBGD): CSF studies and response to pulse steroid treatment. Mov Disord, 11 (Suppl 1): 160.
134. STRAFELLA A., ASHBY P., LANG A.E. (1997). Reflex myoclonus in corticobasal degeneration involves a transcortical pathway. Mov Disord, 12: 360-369.
135. TEDESCHI G., LITVAN I., BONAVITA S., BERTOLINO A. et al. (1997). Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain, 120: 1541-1552.
136. THOMPSON P.D., DAY B.L., ROTHWELI J.C., BROWN P. et al. (1994). The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain, 117: 1197-1207.
137. TOKUMARU A.M., O'UCHI T., KURU Y., MAKI T. et al. (1996). Corticobasal degeneration: MR with histopathologic comparison. Amer J Neuroradiol, 17: 1849-1852.
138. TSUCHIYA K, MIYAZAKI H., IKEDA K., WATABIKI S. et al. (1997a). Serial brain CT in corticobasal degeneration: Radiological and pathological correlation of two autopsy cases. J Neurol Sci, 152: 23-29.
139. TSUCHIYA K., IKEDA K., UCHIHARA T., ODA T. et al. (1997b). Distribution of cerebral cortical lesions in corticobasal degeneration: A clinicopathological study of five autopsy cases in Japan. Acta Neuropathol, 94: 416-424.
140. UCHIHARA T., MITANI K., MORI H., KONDO H. et al. (1994). Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy. Acta Neuropathol, 88: 379-383.
141. VALLS-SOLÉ J., VALLDEORIOLA F., TOLOSA E., MARTI M.J. (1997). Distinctive abnormalities of facial reflexes in patients with progressive supranuclear palsy. Brain, 120: 1877-1883.
142. VÉRIN M., RANCUREL G., DE MARCO O., EDAN G. (1997). First familial cases of corticobasal degeneration. Mov Disord, 12 (supplement 1): 55.
143. VERMERSCH P., ROBITAILLE Y., BERNIER L. WATTEZ A., et al. (1994). Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: Evidence for general cortical involvement. Acta Neuropathol, 87: 572-577.
144. VIDAILHET M. (1997). Critères cliniques de diagnostic des dégénérescences corticobasales. Encycl Med Chir (Elsevier, Paris), Neurologie, 17-062-A-15, 4 p.
145. VIDAILHET M., RIVAUD S., GOUIDER-KHOUJA N., PILLON B. et al. (1994). Eye movements in parkinsonian syndromes. Ann Neurol, 35: 420-426.
146. WAKABAYASHI K., OYANAGI K., MAKIFUCHI T., IKUTA F. et al. (1994). Corticobasal degeneration: Etiopathological significance of cytoskeletal alterations. Acta Neuropathol, 87: 545-553.
147. WATTS R.L., BREWER R.L. (1996). Cortical-basal ganglionic degeneration: Classical clinical features and natural history. Mov Disord, 11: 346-357.
148. WATTS R.L., BREWER R.L., SCHNEIDER J.A., MIRRA S.S. (1997). Corticobasal Degeneration. In Watts R.L, Koller W.C. (eds.), Movement Disorders: Neurologic principles and practice, pp. 611-621. McGraw Hill, New York.
149. WATTS R.L., MIRRA S.S., RICHARDSON E.P. (1994). Corticobasal ganglionic degeneration. In Marsden C.D, Fahn S. (eds.), Movement Disorders, Vol. 3, pp. 282-299. Butterworth-Heinemenn, Oxford.
150. WATTS R.L., MIRRA S.S., YOUNG R.R., BURGER P.C. et al. (1989). Cortico-basal ganglionic degeneration (CBGD) with neuronal achromasia: Clinical-pathological study of two cases. Neurology, 39: 140.
151. WATTS R.L, WILLIAMS R.S., GROWDON J.D., YOUNG R.R. et al. (1985). Corticobasal ganglionic degeneration. Neurology, 35: 178.
152. WENNING G.K., LITVAN I., JANKOVIC J., GRANATA R. et al. (1998). Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry, 64: 184-189.
153. WENNING G.K., LITVAN I., MANGONE C.A., GRANATA R. et al. (1997a). A multicenter clinicopathological study of corticobasal ganglionic degeneration. Ann Neurol, 42: 407.
154. WENNING G.K., TISON F., BEN SHLOMO Y., DANIEL S.E. et al. (1997b). Multiple system atrophy: A review of 203 pathologically proven cases. Mov Disord, 12: 133-147.
155. WILSON R.E., BURNS R.S., KESSLER R.M., SHANNON K. et al. (1990). Evaluation of early brain changes in corticobasal ganglionic degeneration. Ann Neurol, 28: 267.
156. WOJCIESZEK J., LANG A.E., JANKOVIC J., GREENE P. et al. (1994). What is it? Case 1, 1994: Rapidly progressive aphasia, apraxia, dementia, myoclonus, and Parkinsonism. Mov Disord, 9: 358-366.